AARD
AARD
US0029421007
Aardvark Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
62.725.000 22.668.000
176.7%
Operating Income -62.725.000 -22.668.000
176.7%
Pretax Income -57.591.000 -20.588.000
179.7%
Net Income Common Stockholders -57.591.000 -20.588.000
179.7%
-- --
--
-- --
--
ende